Insider · CIK 0001827198

Laponis Adam

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001827198

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-09	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−2,462 sh	$156.30	−$385K	98,114
2026-10-02	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−8,057 sh	$188.88	−$1.52M	100,576
2026-08-21	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−1,965 sh	$139.07	−$273K	108,633
2026-07-09	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−2,399 sh	$94.33	−$226K	110,276
2026-05-29	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−4,000 sh	$70.00	−$280K	112,675
2026-05-21	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−2,019 sh	$53.26	−$108K	116,675
2026-04-17	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−4,000 sh	$60.00	−$240K	118,694
2026-04-14	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−3,000 sh	$55.00	−$165K	122,694
2026-04-09	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−2,597 sh	$49.89	−$130K	125,694
2026-02-23	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−2,085 sh	$46.71	−$97.4K	128,291
2026-02-12	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−7,000 sh	$50.00	−$350K	130,031
2026-01-13	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−3,000 sh	$40.00	−$120K	137,031
2026-01-09	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−2,738 sh	$35.26	−$96.5K	140,031
2025-11-21	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−887 sh	$26.50	−$23.5K	142,769
2025-11-18	TWSTTwist Bioscience CorpA Award	Chief Financial Officer	AAward	+32.6K sh	—	—	143,656
2025-10-30	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−5,517 sh	$31.44	−$173K	111,008
2025-10-28	TWSTTwist Bioscience CorpA Award	Chief Financial Officer	AAward	+25K sh	—	—	116,525
2025-10-09	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−2,517 sh	$32.92	−$82.9K	91,525
2025-10-08	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−3,000 sh	$31.15	−$93.5K	94,042
2025-10-06	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−5,875 sh	$32.19	−$189K	97,042
2025-08-21	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−918 sh	$25.96	−$23.8K	102,917
2025-07-09	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−2,449 sh	$38.15	−$93.4K	103,569
2025-05-21	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−936 sh	$29.75	−$27.8K	106,018
2025-04-09	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−2,542 sh	$34.97	−$88.9K	106,954
2025-02-21	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−918 sh	$44.18	−$40.6K	109,496
2025-01-10	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−5,886 sh	$43.26	−$255K	110,096
2024-12-04	TWSTTwist Bioscience CorpA Award	Chief Financial Officer	AAward	+26.7K sh	—	—	115,982
2024-11-06	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−4,160 sh	$44.60	−$186K	89,237
2024-11-04	TWSTTwist Bioscience CorpA Award	Chief Financial Officer	AAward	+20K sh	—	—	93,397
2024-10-09	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−856 sh	$41.81	−$35.8K	73,397
2024-07-09	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−842 sh	$48.91	−$41.2K	73,602
2024-04-09	TWSTTwist Bioscience CorpS Sale	Chief Financial Officer	SSale	−556 sh	$33.16	−$18.4K	74,444
2024-01-08	TWSTTwist Bioscience CorpA Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2024-01-08	TWSTTwist Bioscience CorpA Award	Chief Financial Officer	AAward	+25K sh	—	—	75,000
2023-11-20	Eargo, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−33 sh	$2.60	−$85.8	258
2023-11-17	Eargo, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−19 sh	$2.56	−$48.64	291
2023-11-15	Eargo, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−2,842 sh	$2.55	−$7,247.1	310
2023-08-17	Eargo, Inc.S Sale	Chief Financial Officer	SSale	−19 sh	$3.24	−$61.471	3,152
2023-08-15	Eargo, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+97.5K sh	—	—	97,500
2023-08-15	Eargo, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+82.5K sh	—	—	82,500
2023-08-15	Eargo, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−82.5K sh	—	—	0
2023-08-15	Eargo, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+82.5K sh	—	—	82,500
2023-08-15	Eargo, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−82.5K sh	—	—	0
2023-08-15	Eargo, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+824 sh	—	—	824
2023-08-15	Eargo, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−824 sh	—	—	0
2023-05-17	Eargo, Inc.S Sale	Chief Financial Officer	SSale	−19 sh	$4.69	−$89.112	3,171
2023-02-17	Eargo, Inc.S Sale	Chief Financial Officer	SSale	−21 sh	$7.37	−$154.772	3,190
2023-02-01	Eargo, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+82.5K sh	—	—	82,500
2023-02-01	Eargo, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+82.5K sh	—	—	82,500
2022-11-22	Eargo, Inc.X Exercise of In-Money	Chief Financial Officer	XExercise of In-Money	+4,995 sh	$0.50	+$2,497.5	64,222

Recent filings

Accepted (ET)
Oct 134
Laponis Adam0001214659-26-012823
SEC(opens sec.gov)
Oct 54
Laponis Adam0001214659-26-012549
SEC(opens sec.gov)
Aug 254
Laponis Adam0001214659-26-010829
SEC(opens sec.gov)
Jul 134
Laponis Adam0001214659-26-008480
SEC(opens sec.gov)
Jun 24
Laponis Adam0001214659-26-007029
SEC(opens sec.gov)
May 264
Laponis Adam0001214659-26-006712
SEC(opens sec.gov)
Apr 214
Laponis Adam0001214659-26-004893
SEC(opens sec.gov)
Apr 164
Laponis Adam0001214659-26-004735
SEC(opens sec.gov)
Apr 134
Laponis Adam0001214659-26-004601
SEC(opens sec.gov)
Feb 254
Laponis Adam0001214659-26-002442
SEC(opens sec.gov)
Feb 134
Laponis Adam0001214659-26-001737
SEC(opens sec.gov)
Jan 154
Laponis Adam0001214659-26-000509
SEC(opens sec.gov)
Jan 134
Laponis Adam0001214659-26-000423
SEC(opens sec.gov)
Nov 254
Laponis Adam0001214659-25-017219
SEC(opens sec.gov)
Nov 204
Laponis Adam0001214659-25-017001
SEC(opens sec.gov)
Nov 34
Laponis Adam0001214659-25-015763
SEC(opens sec.gov)
Oct 304
Laponis Adam0001214659-25-015583
SEC(opens sec.gov)
Oct 104
Laponis Adam0001214659-25-014856
SEC(opens sec.gov)
Oct 84
Laponis Adam0001214659-25-014777
SEC(opens sec.gov)

Companies

Address

C/O TWIST BIOSCIENCE CORPORATION 681 GATEWAY BLVD

SOUTH SAN FRANCISCO, CA, 94080